MEDICuba SA is one of the largest importers of pharmaceuticals and medical devices in the Republic of Cuba. The MEDICuba SA board of management highly appreciated the importance of developing bilateral commercial relationship with JSC Pharmasyntez.

Cuba is the first Latin American country where JSC Pharmasyntez starts to register its drug products. At the date, six ARV and antineoplastic drugs from the Pharmasyntez Group’s portfolio are under approval for the purpose of their subsequent commercialization through MEDICuba SA. The next Latin American countries where JSC Pharmasyntez is going to register its drugs are Ecuador and Mexico.

“Cuba is one of the priority markets in Latin America for us. We established strong partnership relations and we hope to contribute to health of the Russia-friendly Cuban people,” Vikram Punia, president of the Pharmasyntez Group, said.

May we remind that recently JSC Pharmasyntez was entered in the consolidated list of manufacturers implementing the Corporate Competitiveness Enhancement Programs.